The impact of low-threshold methadone maintenance treatment on mortality in a Canadian setting

Seonaid Nolan1, Kanna Hayashi1, M-J Milloy1

  • 1British Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital, 608-1081 Burrard Street, Vancouver, BC, Canada V6Z 1Y6; Department of Medicine, University of British Columbia, St. Paul's Hospital, 608-1081 Burrard Street, Vancouver, BC, Canada V6Z 1Y6.

Abstract

Insights

Methadone maintenance therapy (MMT) significantly reduces mortality in people who inject drugs (PWID). This study shows low-threshold MMT is associated with improved survival rates in this high-risk population.

Area of Science:

  • Addiction Medicine
  • Public Health
  • Epidemiology

Background:

  • Opioid use disorder (OUD) is a significant public health issue.
  • Methadone maintenance therapy (MMT) is an effective OUD treatment.
  • The impact of MMT on mortality and optimal delivery strategies require further investigation.

Purpose of the Study:

  • To estimate the effect of low-threshold MMT on all-cause mortality.
  • To examine the association between MMT and survival among persons who inject drugs (PWID).
  • To assess MMT in a setting with universal healthcare and readily available methadone.

Main Methods:

  • Prospective cohort studies of PWID in Vancouver, Canada (1996-2011).
  • Data linkage with provincial vital statistics to determine mortality rates.
  • Multivariable extended Cox regression analysis to estimate the association of MMT with mortality.

Main Results:

  • A total of 2335 PWID were observed for 15027 person-years, with 511 deaths.
  • The observed mortality rate was 3.4 deaths per 100 person-years.
  • MMT enrollment was associated with significantly lower mortality (AHR=0.73, 95% CI: 0.61-0.88) after adjustment for confounders.

Conclusions:

  • Despite high mortality rates among PWID, low-threshold MMT participation was linked to improved survival.
  • These findings reinforce the benefits of accessible MMT in reducing drug-related harms.
  • Low-threshold MMT is a crucial strategy for improving outcomes in PWID.

Related Concept Videos

Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
333
Therapeutic Drug Monitoring: Overview and Classification01:16

Therapeutic Drug Monitoring: Overview and Classification

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
522
Therapeutic Drug Monitoring: Drug Analysis Methods01:26

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
295
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.5K
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
3.0K
Phase II Reactions: Methylation Reactions01:17

Phase II Reactions: Methylation Reactions

Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
877